Advertisement Invatec launches new IN.PACT balloon catheter - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Invatec launches new IN.PACT balloon catheter

Invatec has announced the European launch of a new peripheral balloon, the IN.PACT Amphirion paclitaxel-eluting PTA balloon catheter.

This is the first drug-eluting catheter designed specifically to treat atherosclerosis in arteries located below the knee, the company said.

IN.PACT features FreePac, a proprietary coating that frees and separates paclitaxel molecules and facilitates their absorption into the wall of the artery.

Invatec plans to launch a randomized trial, the IN.PACT Deep study, in the first half of 2009, to provide additional data about the effectiveness of the new treatment concept.